Nehal Gupta

1.1k total citations · 1 hit paper
18 papers, 836 citations indexed

About

Nehal Gupta is a scholar working on Molecular Biology, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Nehal Gupta has authored 18 papers receiving a total of 836 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 8 papers in Oncology and 3 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Nehal Gupta's work include Cancer Cells and Metastasis (3 papers), HER2/EGFR in Cancer Research (3 papers) and Cancer-related Molecular Pathways (3 papers). Nehal Gupta is often cited by papers focused on Cancer Cells and Metastasis (3 papers), HER2/EGFR in Cancer Research (3 papers) and Cancer-related Molecular Pathways (3 papers). Nehal Gupta collaborates with scholars based in United States, India and South Korea. Nehal Gupta's co-authors include Sanjay Srivastava, Sahdeo Prasad, Itishree Kaushik, Sharavan Ramachandran, Sangeeta Srivastava, Alok Ranjan, Kshitij Verma, Stephen E. Wright, Suyash Srivastava and Hiranmoy Das and has published in prestigious journals such as Cancer Research, Scientific Reports and International Journal of Molecular Sciences.

In The Last Decade

Nehal Gupta

18 papers receiving 828 citations

Hit Papers

Role of Phytochemicals in Cancer Prevention 2019 2026 2021 2023 2019 50 100 150 200 250

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Nehal Gupta United States 12 479 168 152 101 87 18 836
Alok Ranjan United States 18 610 1.3× 242 1.4× 221 1.5× 106 1.0× 61 0.7× 38 1.1k
Jin‐Nyoung Ho South Korea 18 482 1.0× 137 0.8× 105 0.7× 116 1.1× 50 0.6× 51 924
Lokesh Dalasanur Nagaprashantha United States 15 581 1.2× 164 1.0× 115 0.8× 61 0.6× 45 0.5× 23 961
Rachana Garg United States 16 679 1.4× 177 1.1× 228 1.5× 54 0.5× 79 0.9× 24 970
Youn Kyung Choi South Korea 19 440 0.9× 157 0.9× 133 0.9× 59 0.6× 57 0.7× 36 957
Anqi Zeng China 17 435 0.9× 131 0.8× 136 0.9× 54 0.5× 52 0.6× 45 858
T. R. Santhosh Kumar India 19 484 1.0× 135 0.8× 99 0.7× 53 0.5× 53 0.6× 40 992
Qingdi Quentin Li China 18 393 0.8× 183 1.1× 133 0.9× 58 0.6× 45 0.5× 28 841
Tae Woo Kim South Korea 16 477 1.0× 107 0.6× 159 1.0× 60 0.6× 102 1.2× 34 820
Maria Rita Emma Italy 18 456 1.0× 116 0.7× 152 1.0× 69 0.7× 72 0.8× 25 846

Countries citing papers authored by Nehal Gupta

Since Specialization
Citations

This map shows the geographic impact of Nehal Gupta's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nehal Gupta with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nehal Gupta more than expected).

Fields of papers citing papers by Nehal Gupta

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nehal Gupta. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nehal Gupta. The network helps show where Nehal Gupta may publish in the future.

Co-authorship network of co-authors of Nehal Gupta

This figure shows the co-authorship network connecting the top 25 collaborators of Nehal Gupta. A scholar is included among the top collaborators of Nehal Gupta based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nehal Gupta. Nehal Gupta is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Gupta, Nehal, et al.. (2024). Proguanil Suppresses Breast Tumor Growth In Vitro and In Vivo by Inducing Apoptosis via Mitochondrial Dysfunction. Cancers. 16(5). 872–872. 1 indexed citations
2.
Kim, Ji Won, et al.. (2022). Capicua suppresses YAP1 to limit tumorigenesis and maintain drug sensitivity in human cancer. Cell Reports. 41(1). 111443–111443. 8 indexed citations
3.
4.
Gupta, Nehal, et al.. (2022). Effect of Vibratory Inhibition and Pelvic Stabilization Exercise on Tone, Balance and Gross Motor Function in Spastic Cerebral Palsy- A Comparative Study. Journal of Pharmaceutical Research International. 57–67. 1 indexed citations
5.
Gupta, Nehal, et al.. (2021). Atovaquone Suppresses Triple-Negative Breast Tumor Growth by Reducing Immune-Suppressive Cells. International Journal of Molecular Sciences. 22(10). 5150–5150. 26 indexed citations
6.
Gupta, Nehal & Sanjay Srivastava. (2021). Atovaquone Suppresses the Growth of Metastatic Triple-Negative Breast Tumors in Lungs and Brain by Inhibiting Integrin/FAK Signaling Axis. Pharmaceuticals. 14(6). 521–521. 11 indexed citations
7.
Srivastava, Suyash, et al.. (2020). Low Dose of Penfluridol Inhibits VEGF-Induced Angiogenesis. International Journal of Molecular Sciences. 21(3). 755–755. 15 indexed citations
8.
Gupta, Nehal, et al.. (2020). Free Radicals as a Double-Edged Sword: The Cancer Preventive and Therapeutic Roles of Curcumin. Molecules. 25(22). 5390–5390. 118 indexed citations
9.
Ranjan, Alok, Sharavan Ramachandran, Nehal Gupta, et al.. (2019). Role of Phytochemicals in Cancer Prevention. International Journal of Molecular Sciences. 20(20). 4981–4981. 261 indexed citations breakdown →
10.
Gupta, Nehal, Parul Gupta, & Sanjay Srivastava. (2019). Penfluridol overcomes paclitaxel resistance in metastatic breast cancer. Scientific Reports. 9(1). 5066–5066. 43 indexed citations
11.
Prasad, Sahdeo, Sharavan Ramachandran, Nehal Gupta, Itishree Kaushik, & Sanjay Srivastava. (2019). Cancer cells stemness: A doorstep to targeted therapy. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 1866(4). 165424–165424. 114 indexed citations
12.
Gupta, Nehal & Sanjay Srivastava. (2019). Atovaquone: An Antiprotozoal Drug Suppresses Primary and Resistant Breast Tumor Growth by Inhibiting HER2/β-Catenin Signaling. Molecular Cancer Therapeutics. 18(10). 1708–1720. 31 indexed citations
13.
Verma, Kshitij, Nehal Gupta, Tianzhu Zang, et al.. (2018). AKR1C3 Inhibitor KV-37 Exhibits Antineoplastic Effects and Potentiates Enzalutamide in Combination Therapy in Prostate Adenocarcinoma Cells. Molecular Cancer Therapeutics. 17(9). 1833–1845. 38 indexed citations
14.
Gupta, Parul, Nehal Gupta, Neel M. Fofaria, Alok Ranjan, & Sanjay Srivastava. (2018). HER2-mediated GLI2 stabilization promotes anoikis resistance and metastasis of breast cancer cells. Cancer Letters. 442. 68–81. 34 indexed citations
15.
Kim, Chang-Geun, Hyemin Lee, Nehal Gupta, et al.. (2017). Role of Forkhead Box Class O proteins in cancer progression and metastasis. Seminars in Cancer Biology. 50. 142–151. 88 indexed citations
16.
Gupta, Nehal, Parul Gupta, & Sanjay Srivastava. (2017). Abstract 3176: Inhibition of HER2/β-catenin signaling by penfluridol overcomes resistance to paclitaxel in breast cancer. Cancer Research. 77(13_Supplement). 3176–3176. 1 indexed citations
18.
Verma, Kshitij, Tianzhu Zang, Nehal Gupta, T.M. Penning, & Paul C. Trippier. (2016). Selective AKR1C3 Inhibitors Potentiate Chemotherapeutic Activity in Multiple Acute Myeloid Leukemia (AML) Cell Lines. ACS Medicinal Chemistry Letters. 7(8). 774–779. 37 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026